echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Synthetic Routes of 4,4'-(6-chloropyriMidine-2,4-diyl)diMorpholine

    The Synthetic Routes of 4,4'-(6-chloropyriMidine-2,4-diyl)diMorpholine

    • Last Update: 2023-05-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    4,4'-(6-Chloropyrimidine-2,4-diyl)diMorpholine is a synthetic compound used in various applications in the chemical industry.
    The compound is synthesized through several routes, each with its advantages and disadvantages.
    In this article, we will discuss three synthetic routes commonly used to produce 4,4'-(6-chloropyrimidine-2,4-diyl)diMorpholine.


    Route 1: via N-Chlorosuccinimide


    This is a typical synthetic route for 4,4'-(6-chloropyrimidine-2,4-diyl)diMorpholine.
    The process involves the following steps:


    1. Preparation of N-Chlorosuccinimide: N-Chlorosuccinimide is prepared by treating succinimide with N-chloroethyl chloride in the presence of a solvent like dichloromethane.
    2. Condensation of N-Chlorosuccinimide with 2,4-Dichloropyrimidine: N-Chlorosuccinimide is condensed with 2,4-dichloropyrimidine in the presence of a solvent like DMF.
      This condensation results in the formation of N-chloro-2,4-dimethyl-6-nitropyridine.
    3. Ring-Closing Metathesis of N-Chloro-2,4-dimethyl-6-nitropyridine: The N-chloro-2,4-dimethyl-6-nitropyridine from step 2 undergoes ring-closing metathesis in the presence of a catalyst like ruthenium catalyst and a solvent like toluene.
      This results in the formation of 4,4'-(6-chloropyrimidine-2,4-diyl)diMorpholine.

    Advantages of this route:


    • This route is straightforward and easy to execute.
    • It uses readily available reagents.
    • The yield of the product is good.

    Disadvantages of this route:


    • The use of N-chlorosuccinimide can be hazardous.
    • The use of a large amount of toluene can be environmentally unfriendly.
    • The ring-closing metathesis step requires the use of a catalyst, which can be expensive.

    Route 2: via N-Bromosuccinimide


    This synthetic route involves the following steps:


    1. Preparation of N-Bromosuccinimide: N-Bromosuccinimide is prepared by treating succinimide with N-bromoethyl chloride in the presence of a solvent like dichloromethane.
    2. Condensation of N-Bromosuccinimide with 2,4-Dichloropyrimidine: N-Bromosuccinimide is condensed with 2,4-dichloropyrimidine in the presence of a solvent like DMF.
      This condensation results in the formation of N-bromo-2,4-dimethyl-6-nitropyridine.
    3. Ring-Closing Metathesis of N-Bromo-2,4-dimethyl-6-nitropyridine: The N-bromo-2,4-dimethyl-6-nitropyridine from step 2 undergoes ring-closing metathesis in the presence of a catalyst like ruthenium catalyst and a solvent like toluene.
      This results in the formation of 4,4'-(6-chloropyrimidine-2,4-diyl)diMorpholine.

    Advantages of this route:


    • This route is also straightforward and easy
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.